Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation

Ann Hematol. 2002 Jun;81(6):354-6. doi: 10.1007/s00277-002-0459-2.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / therapy*
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Interleukin-11 / therapeutic use*
  • Recombinant Proteins / therapeutic use*
  • Thrombocytopenia / prevention & control*

Substances

  • Antineoplastic Agents
  • Interleukin-11
  • Recombinant Proteins
  • oprelvekin